Astera Labs, Inc. $ALAB Shares Acquired by American Century Companies Inc.

Key Points

• American Century Companies Inc. increased its stake in Astera Labs, Inc. by 46.9% in Q1 2023, acquiring an additional 2,165 shares, bringing its total holdings to 6,783 shares valued at $405,000.
• Astera Labs has received mixed ratings from analysts, with Northland Securities lowering their rating to "market perform," while Evercore ISI raised their price target to $215.00.
• Insiders have recently sold significant shares, including Director Jack R. Lazar, who sold 22,500 shares for $4,014,450, representing an 18.77% decrease in his ownership.

American Century Companies Inc. raised its holdings in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 46.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,783 shares of the company's stock after purchasing an additional 2,165 shares during the period. American Century Companies Inc.'s holdings in Astera Labs were worth $405,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Astera Labs by 2,824.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock worth $20,467,000 after purchasing an additional 149,240 shares during the last quarter. Aigen Investment Management LP lifted its stake in shares of Astera Labs by 50.9% during the 1st quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock worth $1,069,000 after purchasing an additional 6,045 shares during the period. Pacific Point Advisors LLC lifted its stake in shares of Astera Labs by 75.0% during the 1st quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock worth $418,000 after purchasing an additional 3,000 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in shares of Astera Labs by 73.6% during the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock worth $954,000 after purchasing an additional 6,783 shares during the last quarter. Finally, Taylor Frigon Capital Management LLC purchased a new stake in shares of Astera Labs in the first quarter valued at $1,887,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the firm's stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $188.70, for a total value of $1,887,000.00. Following the transaction, the general counsel owned 161,573 shares of the company's stock, valued at $30,488,825.10. This trade represents a 5.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the transaction, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,832,489 shares of company stock valued at $264,172,396 over the last quarter. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Performance

Shares of ALAB stock traded up $15.88 on Wednesday, hitting $230.37. The stock had a trading volume of 6,194,989 shares, compared to its average volume of 4,644,045. The stock's 50 day moving average is $149.50 and its 200-day moving average is $101.61. The firm has a market capitalization of $38.29 billion, a price-to-earnings ratio of 411.38, a P/E/G ratio of 5.44 and a beta of 1.48. Astera Labs, Inc. has a 52-week low of $38.14 and a 52-week high of $230.88.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Stifel Nicolaus set a $145.00 target price on Astera Labs and gave the stock a "buy" rating in a research report on Monday, August 4th. Evercore ISI raised their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. William Blair started coverage on shares of Astera Labs in a report on Thursday, May 22nd. They issued an "outperform" rating for the company. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research note on Friday, August 29th. Finally, Zacks Research raised shares of Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $142.00.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.